SWK Holdings Corporation focuses on specialty finance and asset management business.
SWK Holdings Corporation (“SWK”) is a publicly traded, specialized finance company with a focus on the global healthcare sector. SWK partners with ethical product marketers and royalty holders to provide flexible financing solutions at an attractive cost of capital to create long-term value for both SWK’s business partners and its investors.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Dec 15, 2022
Aziyo Biologics
|
Post-IPO Debt | $4M | Biotechnology | Yes |
Mar 7, 2022
Acer Therapeutics
|
Post-IPO Debt | $48.50M | Biotechnology | — |